Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 849

1.
2.

Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer.

Hauser S, Kaminski A, Syring I, Holdenrieder S, Dieckmann KP, Muller SC, Ellinger J.

In Vivo. 2019 Nov-Dec;33(6):1935-1940. doi: 10.21873/invivo.11688.

PMID:
31662522
3.

Pan-viral serology implicates enteroviruses in acute flaccid myelitis.

Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GA, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL, Gelfand AA, Johnson-Kerner BL, Nash K, Krishnamoorthy KS, Chitnis T, Ding JZ, McMillan HJ, Chiu CY, Briggs B, Glaser CA, Yen C, Chu V, Wadford DA, Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson L, Messacar K, Konopka-Anstadt JL, Oberste MS, DeRisi JL, Wilson MR.

Nat Med. 2019 Oct 21. doi: 10.1038/s41591-019-0613-1. [Epub ahead of print]

PMID:
31636453
4.

Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.

Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M.

J Med Internet Res. 2019 Oct 8;21(10):e16287. doi: 10.2196/16287.

5.

The value of tumor markers in men with metastatic prostate cancer undergoing [177 Lu]Lu-PSMA therapy.

Yordanova A, Linden P, Hauser S, Feldmann G, Brossart P, Fimmers R, Essler M, Holdenrieder S, Ahmadzadehfar H.

Prostate. 2019 Oct 3. doi: 10.1002/pros.23912. [Epub ahead of print]

PMID:
31579967
6.

Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.

Papinutto N, Asteggiano C, Bischof A, Gundel TJ, Caverzasi E, Stern WA, Bastianello S, Hauser SL, Henry RG.

J Neuroimaging. 2019 Sep 30. doi: 10.1111/jon.12666. [Epub ahead of print]

PMID:
31571307
7.

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.

Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL.

Brain. 2019 Sep 1;142(9):2787-2799. doi: 10.1093/brain/awz212.

8.

Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.

Krysko KM, Henry RG, Cree BAC, Lin J; University of California, San Francisco MS-EPIC Team, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, Graves JS.

Ann Neurol. 2019 Nov;86(5):671-682. doi: 10.1002/ana.25592. Epub 2019 Oct 2.

PMID:
31486104
9.

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.

Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL.

Neurology. 2019 Nov 5;93(19):e1778-e1786. doi: 10.1212/WNL.0000000000008189. Epub 2019 Sep 4.

PMID:
31484710
10.

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.

Garofano F, Gonzalez-Carmona MA, Skowasch D, Schmidt-Wolf R, Abramian A, Hauser S, Strassburg CP, Schmidt-Wolf IGH.

Int J Mol Sci. 2019 Sep 3;20(17). pii: E4307. doi: 10.3390/ijms20174307. Review.

11.

Peri-adolescent alcohol consumption increases sensitivity and dopaminergic response to nicotine during adulthood in female alcohol-preferring (P) rats: Alterations to α7 nicotinic acetylcholine receptor expression.

Waeiss RA, Knight CP, Carvajal GB, Bell RL, Engleman EA, McBride WJ, Hauser SR, Rodd ZA.

Behav Brain Res. 2019 Dec 30;376:112190. doi: 10.1016/j.bbr.2019.112190. Epub 2019 Aug 29.

PMID:
31473285
12.

Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.

Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M.

J Med Internet Res. 2019 Aug 30;21(8):e14863. doi: 10.2196/14863. Erratum in: J Med Internet Res. 2019 Oct 8;21(10):e16287.

13.

Cytocompatible, Injectable, and Electroconductive Soft Adhesives with Hybrid Covalent/Noncovalent Dynamic Network.

Xu Y, Patsis PA, Hauser S, Voigt D, Rothe R, Günther M, Cui M, Yang X, Wieduwild R, Eckert K, Neinhuis C, Akbar TF, Minev IR, Pietzsch J, Zhang Y.

Adv Sci (Weinh). 2019 May 24;6(15):1802077. doi: 10.1002/advs.201802077. eCollection 2019 Aug 7.

14.

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.

Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J.

JAMA Neurol. 2019 Aug 12. doi: 10.1001/jamaneurol.2019.2137. [Epub ahead of print]

PMID:
31403661
15.

Opposing T cell responses in experimental autoimmune encephalomyelitis.

Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, Ji X, Idoyaga J, Mahajan VB, Steinmetz LM, Chien YH, Hauser SL, Oksenberg JR, Garcia KC, Davis MM.

Nature. 2019 Aug;572(7770):481-487. doi: 10.1038/s41586-019-1467-x. Epub 2019 Aug 7.

PMID:
31391585
16.

Adolescent Intermittent Ethanol Increases the Sensitivity to the Reinforcing Properties of Ethanol and the Expression of Select Cholinergic and Dopaminergic Genes within the Posterior Ventral Tegmental Area.

Hauser SR, Knight CP, Truitt WA, Waeiss RA, Holt IS, Carvajal GB, Bell RL, Rodd ZA.

Alcohol Clin Exp Res. 2019 Sep;43(9):1937-1948. doi: 10.1111/acer.14150. Epub 2019 Aug 21.

PMID:
31329298
17.

Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons.

Rehbach K, Kesavan J, Hauser S, Ritzenhofen S, Jungverdorben J, Schüle R, Schöls L, Peitz M, Brüstle O.

Sci Rep. 2019 Jul 3;9(1):9615. doi: 10.1038/s41598-019-45246-4.

18.

Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"

Cree BAC, Hauser SL.

Ann Neurol. 2019 Sep;86(3):472-473. doi: 10.1002/ana.25536. Epub 2019 Jul 12. No abstract available.

PMID:
31251816
19.

Adjuvant drug-assisted bone healing: Part III - Further strategies for local and systemic modulation.

Rothe R, Schulze S, Neuber C, Hauser S, Rammelt S, Pietzsch J.

Clin Hemorheol Microcirc. 2019 Jun 3. doi: 10.3233/CH-199104. [Epub ahead of print]

PMID:
31177207
20.

Adjuvant drug-assisted bone healing: Part II - Modulation of angiogenesis.

Rothe R, Schulze S, Neuber C, Hauser S, Rammelt S, Pietzsch J.

Clin Hemorheol Microcirc. 2019 Jun 3. doi: 10.3233/CH-199103. [Epub ahead of print]

PMID:
31177206
21.

Adjuvant drug-assisted bone healing: Part I - Modulation of inflammation.

Rothe R, Schulze S, Neuber C, Hauser S, Rammelt S, Pietzsch J.

Clin Hemorheol Microcirc. 2019 Jun 3. doi: 10.3233/CH-199102. [Epub ahead of print]

PMID:
31177205
22.

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background.

Ullrich M, Richter S, Seifert V, Hauser S, Calsina B, Martínez-Montes ÁM, Ter Laak M, Ziegler CG, Timmers H, Eisenhofer G, Robledo M, Pietzsch J.

Cancers (Basel). 2019 May 28;11(6). pii: E743. doi: 10.3390/cancers11060743.

23.

Landscape genetic inferences vary with sampling scenario for a pond-breeding amphibian.

Seaborn T, Hauser SS, Konrade L, Waits LP, Goldberg CS.

Ecol Evol. 2019 Apr 15;9(9):5063-5078. doi: 10.1002/ece3.5023. eCollection 2019 May.

24.

Conditioned stimuli affect ethanol-seeking by female alcohol-preferring (P) rats: the role of repeated-deprivations, cue-pretreatment, and cue-temporal intervals.

Hauser SR, Deehan GA Jr, Knight CP, Waeiss RA, Truitt WA, Johnson PL, Bell RL, McBride WJ, Rodd ZA.

Psychopharmacology (Berl). 2019 Sep;236(9):2835-2846. doi: 10.1007/s00213-019-05264-6. Epub 2019 May 16.

PMID:
31093721
25.

Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions.

Greenfield AL, Hauser SL.

Neurotherapeutics. 2019 Apr;16(2):314-318. doi: 10.1007/s13311-019-00740-5. Review. No abstract available.

PMID:
31087242
26.

Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.

Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR.

J Autoimmun. 2019 Jul;101:56-69. doi: 10.1016/j.jaut.2019.04.003. Epub 2019 Apr 19.

PMID:
31010726
27.

A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.

Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, Anderson KM, Misra MK, Nemat-Gorgani N, Osoegawa K, Santaniello A, Renschen A, Marin WM, Dandekar R, Parham P, Tanner CM, Hauser SL, Fernandez-Viña M, Oksenberg JR.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7419-7424. doi: 10.1073/pnas.1821778116. Epub 2019 Mar 25.

28.

Silent progression in disease activity-free relapsing multiple sclerosis.

University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL.

Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.

29.

Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.

Mayer L, Kappos L, Racke MK, Rammohan K, Traboulsee A, Hauser SL, Julian L, Köndgen H, Li C, Napieralski J, Zheng H, Wolinsky JS.

Mult Scler Relat Disord. 2019 May;30:236-243. doi: 10.1016/j.msard.2019.01.044. Epub 2019 Jan 28.

PMID:
30844611
30.

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.

Turner B, Cree BAC, Kappos L, Montalban X, Papeix C, Wolinsky JS, Buffels R, Fiore D, Garren H, Han J, Hauser SL.

J Neurol. 2019 May;266(5):1182-1193. doi: 10.1007/s00415-019-09248-6. Epub 2019 Feb 28.

31.

Apelin and apelin receptor expression in renal cell carcinoma.

Tolkach Y, Ellinger J, Kremer A, Esser L, Müller SC, Stephan C, Jung K, Toma M, Kristiansen G, Hauser S.

Br J Cancer. 2019 Mar;120(6):633-639. doi: 10.1038/s41416-019-0396-7. Epub 2019 Feb 20.

PMID:
30783205
32.

Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study.

Eckart A, Hauser SI, Kutz A, Haubitz S, Hausfater P, Amin D, Amin A, Huber A, Mueller B, Schuetz P.

BMJ Open. 2019 Jan 17;9(1):e024636. doi: 10.1136/bmjopen-2018-024636.

33.

Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.

Waeiss RA, Knight CP, Hauser SR, Pratt LA, McBride WJ, Rodd ZA.

Psychopharmacology (Berl). 2019 Jun;236(6):1887-1900. doi: 10.1007/s00213-019-5174-y. Epub 2019 Feb 13.

PMID:
30758525
34.

Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC.

JCI Insight. 2019 Mar 21;4(6). pii: 126599. doi: 10.1172/jci.insight.126599. eCollection 2019 Mar 21.

35.

pRNFL as a marker of disability worsening in the medium/long term in patients with MS.

Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 21;6(2):e533. doi: 10.1212/NXI.0000000000000533. eCollection 2019 Mar. No abstract available.

36.

Asymmetrical gene flow of the recently delisted passerine black-capped vireo (Vireo atricapilla) indicates source-sink dynamics in central Texas.

Hauser SS, Walker L, Leberg PL.

Ecol Evol. 2018 Dec 10;9(1):463-470. doi: 10.1002/ece3.4764. eCollection 2019 Jan.

37.

Distinction of self-produced touch and social touch at cortical and spinal cord levels.

Boehme R, Hauser S, Gerling GJ, Heilig M, Olausson H.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2290-2299. doi: 10.1073/pnas.1816278116. Epub 2019 Jan 22.

38.

Validation of the hospital frailty risk score in a tertiary care hospital in Switzerland: results of a prospective, observational study.

Eckart A, Hauser SI, Haubitz S, Struja T, Kutz A, Koch D, Neeser O, Meier MA, Mueller B, Schuetz P.

BMJ Open. 2019 Jan 15;9(1):e026923. doi: 10.1136/bmjopen-2018-026923.

39.

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus.

Schuster S, Saravanakumar S, Schöls L, Hauser S.

Stem Cell Res. 2019 Jan;34:101378. doi: 10.1016/j.scr.2018.101378. Epub 2018 Dec 21.

40.

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL.

Mult Scler. 2018 Dec 19:1352458518814117. doi: 10.1177/1352458518814117. [Epub ahead of print]

PMID:
30566027
41.

Virulence factor-dependent basolateral invasion of choroid plexus epithelial cells by pathogenic Escherichia coli in vitro.

Rose R, Häuser S, Stump-Guthier C, Weiss C, Rohde M, Kim KS, Ishikawa H, Schroten H, Schwerk C, Adam R.

FEMS Microbiol Lett. 2018 Dec 1;365(24). doi: 10.1093/femsle/fny274.

PMID:
30476042
42.

Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer.

Yordanova A, Linden P, Hauser S, Meisenheimer M, Kürpig S, Feldmann G, Gaertner FC, Essler M, Ahmadzadehfar H.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1073-1080. doi: 10.1007/s00259-018-4222-x. Epub 2018 Nov 24.

PMID:
30474706
43.

Inhibition of Lithium Sensitive Orai1/ STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin.

Sukkar B, Hauser S, Pelzl L, Hosseinzadeh Z, Sahu I, Al-Maghout T, Bhuyan AAM, Zacharopoulou N, Stournaras C, Schöls L, Lang F.

Cell Physiol Biochem. 2018;51(1):278-289. doi: 10.1159/000495229. Epub 2018 Nov 19.

44.

Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.

Müller T, Tolkach Y, Stahl D, Steiner S, Hauser S, Ellinger J, Rabien A, Ralla B, Jung K, Stephan C, Kristiansen G.

Clin Genitourin Cancer. 2019 Feb;17(1):e167-e175. doi: 10.1016/j.clgc.2018.10.008. Epub 2018 Oct 23.

PMID:
30448104
45.

Body mass index, but not vitamin D status, is associated with brain volume change in MS.

Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D.

Neurology. 2018 Dec 11;91(24):e2256-e2264. doi: 10.1212/WNL.0000000000006644. Epub 2018 Nov 14.

PMID:
30429274
46.

Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3.

Harmuth T, Prell-Schicker C, Weber JJ, Gellerich F, Funke C, Drießen S, Magg JCD, Krebiehl G, Wolburg H, Hayer SN, Hauser S, Krüger R, Schöls L, Riess O, Hübener-Schmid J.

Front Mol Neurosci. 2018 Oct 10;11:368. doi: 10.3389/fnmol.2018.00368. eCollection 2018.

47.

[Long-term follow up of the serosa-lined and tapered Ileum as an efferent segment of various urinary diversion reservoirs ("Fulda-nipple")].

Stein J, Müller SC, Hauser S, Fechner G.

Aktuelle Urol. 2019 Jul;50(3):268-273. doi: 10.1055/a-0667-8429. Epub 2018 Oct 24. German.

PMID:
30357763
48.

Inconsistent use of multiple comparison corrections in studies of population genetic structure: Are some type I errors more tolerable than others?

Hauser S, Wakeland K, Leberg P.

Mol Ecol Resour. 2019 Jan;19(1):144-148. doi: 10.1111/1755-0998.12947. Epub 2018 Oct 28.

PMID:
30267479
49.

Identification of MS-specific serum miRNAs in an international multicenter study.

Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(5):e491. doi: 10.1212/NXI.0000000000000491. eCollection 2018 Sep.

50.

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.

Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L.

Ann Neurol. 2018 Oct;84(4):527-536. doi: 10.1002/ana.25313.

Supplemental Content

Loading ...
Support Center